Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulation for treating herpes virus infection comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b) quinoxaline

Pharmaceutical formulation for treating herpes virus infection comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b) quinoxaline

US Patent 9119852 · Granted Sep 1, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulation comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H2017
Pharmaceutical formulation comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H2017
Compounds and methods2017
Compounds and methods2017
Methanethione compounds having antiviral activity2016
Methanethione compounds having antiviral activity2016
Thionation process and a thionating agent2015
Thionating agent2015
Identification and classification of virus particles in textured electron microg2014
Method of analyzing cell structures and their components2014
Method for counting and segmenting viral particles in an image2014
Identification and classification of virus particles in textured electron microg2012